{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:42:57Z","timestamp":1793353377158,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11926-023-01126-5","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T01:02:07Z","timestamp":1701910927000},"page":"53-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calcinosis in Juvenile Dermatomyositis\u2014Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-7959","authenticated-orcid":false,"given":"Jucier","family":"Gon\u00e7alves J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-4517","authenticated-orcid":false,"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101768","volume":"36","author":"S Davuluri","year":"2022","unstructured":"Davuluri S, Duvuri B, Lood C, Faghihi-Kashani S, Chung L. Calcinosis in dermatomyositis: Origins and possible therapeutic avenues. Best Pract Res Clin Rheumatol. 2022;36: 101768. https:\/\/doi.org\/10.1016\/j.berh.2022.101768.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1126_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"I Lundberg","year":"2021","unstructured":"Lundberg I, Fujimoto M, Vencovsky J, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7:86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x.","journal-title":"Nat Rev Dis Primers"},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"LJ McCann","year":"2006","unstructured":"\u2022 McCann LJ, Juggins AD, Maillard SM, et al. The Juvenile Dermatomyositis National Registry and 290 Repository (UK and Ireland) - clinical characteristics of children recruited within the first 5 yr. Rheumatology. 2006;45:1255\u201360. https:\/\/doi.org\/10.1093\/rheumatology\/kel099. This study describes a cohort that helps understand the natural history of the disease.","journal-title":"Rheumatology"},{"key":"1126_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1590\/S0482-50042012000400007","volume":"52","author":"G Clemente","year":"2012","unstructured":"Clemente G, Piotto DGP, Barbosa C, et al. High frequency of calcinosis in juvenile 293 dermatomyositis: a risk factor study. Rev Bras Reumatol. 2012;52:549\u201353.","journal-title":"Rev Bras Reumatol"},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/BOR.0b013e32834ff5cd","volume":"24","author":"S Chander","year":"2012","unstructured":"Chander S, Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opin Rheumatol. 2012;24:158\u201364. https:\/\/doi.org\/10.1097\/BOR.0b013e32834ff5cd.","journal-title":"Curr Opin Rheumatol"},{"key":"1126_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102533","volume":"19","author":"MP Chung","year":"2020","unstructured":"Chung MP, Richardson C, Kirakossian D, et al. Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmun Rev. 2020;19: 102533. https:\/\/doi.org\/10.1016\/j.autrev.2020.102533.","journal-title":"Autoimmun Rev"},{"key":"1126_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3899\/jrheum.211393","volume":"49","author":"H Elahmar","year":"2022","unstructured":"Elahmar H, Feldman BM, Johnson SR. Management of calcinosis cutis in rheumatic diseases. J Rheumatol. 2022;49:980\u20139. https:\/\/doi.org\/10.3899\/jrheum.211393.","journal-title":"J Rheumatol"},{"key":"1126_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S0482-50042013000200009","volume":"53","author":"SK Shinjo","year":"2013","unstructured":"Shinjo SK, Souza FH. Update on the treatment of calcinosis in dermatomyositis. Rev Bras Reumatol. 2013;53:211\u20134.","journal-title":"Rev Bras Reumatol"},{"key":"1126_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jaad.2019.07.006","volume":"82","author":"H Traineua","year":"2022","unstructured":"Traineua H, Aggarwal R, Monfort J-B, et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature. J Am Acad Dermatol. 2022;82:317\u201325. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.006.","journal-title":"J Am Acad Dermatol"},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"1126_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103061","volume":"138","author":"B Duvvuri","year":"2023","unstructured":"\u2022\u2022 Duvvuri B, Pachman LM, Hermanson P, et al. Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis. J Autoimmun. 2023;138: 103061. https:\/\/doi.org\/10.1016\/j.jaut.2023.103061. This study highlights possible pathophysiological pathways of calcinosis in JDM.","journal-title":"J Autoimmun"},{"key":"1126_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.55563\/clinexprheumatol\/7k9ajj","volume":"41","author":"MV Mastrolia","year":"2023","unstructured":"Mastrolia MV, Orsini SI, Marrani E, et al. Efficacy of Janus kinase inhibitor baricitinib in the treatment of refractory juvenile dermatomyositis complicated by calcinosis. Clin Exp Rheumatol. 2023;41:402\u20133. https:\/\/doi.org\/10.55563\/clinexprheumatol\/7k9ajj.","journal-title":"Clin Exp Rheumatol"},{"key":"1126_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152133","volume":"58","author":"S Sener","year":"2023","unstructured":"\u2022 Sener S, Basaran O, Batu ED, et al. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature. Semin Arthritis Rheum. 2023;58: 152133. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152133. This study describes a cohort that helps understand the natural history of the disease.","journal-title":"Semin Arthritis Rheum"},{"key":"1126_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152104","volume":"57","author":"P Cancarini","year":"2022","unstructured":"\u2022 Cancarini P, Nozawa T, Whitney K, et al. The clinical features of juvenile dermatomyositis: A single-centre inception cohort. Semin Arthritis Rheum. 2022;57: 152104. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152104. This study describes a cohort that helps understand the natural history of the disease.","journal-title":"Semin Arthritis Rheum"},{"key":"1126_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.55563\/clinexprheumatol\/h0s7tq","volume":"40","author":"K El-Garf","year":"2022","unstructured":"\u2022 El-Garf K, El-Garf A, Salah S, Marzouk H, Farag Y, Mostafa N. A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort. Clin Exp Rheumatol. 2022;40:450\u20136. https:\/\/doi.org\/10.55563\/clinexprheumatol\/h0s7tq. This study describes a cohort that helps understand the epidemiology of the disease.","journal-title":"Clin Exp Rheumatol"},{"key":"1126_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-252814","volume":"15","author":"M Janarthanan","year":"2022","unstructured":"Janarthanan M, Mohan M, Murali A. Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines. BMJ Case Rep. 2022;15: e252814. https:\/\/doi.org\/10.1136\/bcr-2022-252814.","journal-title":"BMJ Case Rep"},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12098-022-04332-8","volume":"89","author":"J Jin","year":"2022","unstructured":"Jin J, Yu H. Use of adalimumab in a child with juvenile dermatomyositis and calcinosis. Indian J Pediatr. 2022;89:1270. https:\/\/doi.org\/10.1007\/s12098-022-04332-8.","journal-title":"Indian J Pediatr"},{"key":"1126_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-249110","volume":"15","author":"JM Linan-Barroso","year":"2022","unstructured":"Linan-Barroso JM, Gonzalez-Estrada A, Garc\u00eda-Morillo JS. Therapy-resistant dermatomyositis with extensive \u2018lumbar belt\u2019 calcinosis. BMJ Case Rep. 2022;15: e249110. https:\/\/doi.org\/10.1136\/bcr-2022-249110.","journal-title":"BMJ Case Rep"},{"key":"1126_CR19","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/acr.23840","volume":"71","author":"J Neely","year":"2019","unstructured":"Neely J, Long CS, Sturrock H, Kim S. Association of short-term ultraviolet radiation exposure and disease severity in juvenile dermatomyositis: results from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care Res (Hoboken). 2019;71:1600\u20135. https:\/\/doi.org\/10.1002\/acr.23840.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1126_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.25259\/IJDVL_297_20","volume":"88","author":"R Nitiyarom","year":"2023","unstructured":"Nitiyarom R, Charuvanji S, Likasitwattanakul S, et al. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center. Indian J Dermatol Venereol Leprol. 2023;88:162\u201370. https:\/\/doi.org\/10.25259\/IJDVL_297_20.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1126_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.810785","volume":"9","author":"N Toplak","year":"2022","unstructured":"Toplak N, Pimpale Chavan P, et al. Is Anti-NXP2 autoantibody a risk factor for calcinosis and poor outcome in juvenile dermatomyositis patients? Case Series Front Pediatr. 2022;9: 810785. https:\/\/doi.org\/10.3389\/fped.2021.810785.","journal-title":"Case Series Front Pediatr"},{"key":"1126_CR22","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/jpc.15595","volume":"57","author":"A Concannon","year":"2021","unstructured":"Concannon A, Han DY. Incidence, severity and clinical manifestations of juvenile dermatomyositis among Maori and Pacific Island compared to European children. J Paediatr Child Health. 2021;57:1881\u20135. https:\/\/doi.org\/10.1111\/jpc.15595.","journal-title":"J Paediatr Child Health"},{"key":"1126_CR23","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2020.56.3.212","volume":"56","author":"CH Chung","year":"2020","unstructured":"Chung CH. Calcinosis universalis in juvenile dermatomyositis. Chonnam Med J. 2020;56: 212213. https:\/\/doi.org\/10.4068\/cmj.2020.56.3.212.","journal-title":"Chonnam Med J"},{"key":"1126_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13075-020-02164-5","volume":"22","author":"R Campanilho-Marques","year":"2020","unstructured":"\u2022 Campanilho-Marques R, Deakin CT, Simou S, et al. Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients. Arthritis Res Ther. 2020;22:79. https:\/\/doi.org\/10.1186\/s13075-020-02164-5. This study describes a cohort that helps understand the disease's response to immunobiologicals.","journal-title":"Arthritis Res Ther"},{"key":"1126_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s13312-020-1712-2","volume":"57","author":"S Giri","year":"2020","unstructured":"Giri S, Parida JR, Dash M, Panda M. pamidronate in treatment of calcinosis in juvenile dermatomyositis. Indian Pediatr. 2020;57:75\u20136.","journal-title":"Indian Pediatr"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.reuma.2018.06.010","volume":"16","author":"CV Lebr\u00f3n","year":"2020","unstructured":"Lebr\u00f3n CV, Montesino MDR, Navarrete VM, Miera FJTS. Treatment with rituximab in juvenile dermatomyositis: effect on calcinosis. Reumatol Clin. 2020;16:368\u201370. https:\/\/doi.org\/10.1016\/j.reuma.2018.06.010.","journal-title":"Reumatol Clin"},{"key":"1126_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.annder.2020.04.016","volume":"147","author":"C Moegle","year":"2020","unstructured":"Moegle C, Lipsker D. Juvenile dermatomyositis: A series of 22 cases. Ann Dermatol Venereol. 2020;147:494\u2013503. https:\/\/doi.org\/10.1016\/j.annder.2020.04.016.","journal-title":"Ann Dermatol Venereol"},{"key":"1126_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.semarthrit.2019.06.014","volume":"50","author":"V Tsaltskan","year":"2020","unstructured":"Tsaltskan V, Aldous A, Serafi S, et al. Long-term outcomes in juvenile myositis patients. Semin Arthritis Rheum. 2020;50:149\u201355. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.014.","journal-title":"Semin Arthritis Rheum"},{"key":"1126_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/rheumatology\/keaa566","volume":"60","author":"U Rathore","year":"2020","unstructured":"Rathore U, Gupta L. Scalp calcinosis in juvenile dermatomyositis. Rheumatology. 2020;60:1569. https:\/\/doi.org\/10.1093\/rheumatology\/keaa566.","journal-title":"Rheumatology"},{"key":"1126_CR30","doi-asserted-by":"publisher","first-page":"4073879","DOI":"10.1155\/2020\/4073879","volume":"28","author":"S Sukumaran","year":"2020","unstructured":"Sukumaran S, Vijayan V. Abatacept in the treatment of juvenile dermatomyositis-associated calcifications in a 16-year-old girl. Case Rep Rheumatol. 2020;28:4073879. https:\/\/doi.org\/10.1155\/2020\/4073879.","journal-title":"Case Rep Rheumatol"},{"key":"1126_CR31","doi-asserted-by":"publisher","DOI":"10.1056\/nejmicm1809669","volume":"381","author":"J Li","year":"2019","unstructured":"Li J, Zhou Z. Calcinosis in juvenile dermatomyositis. N Engl J Med. 2019;381: e31. https:\/\/doi.org\/10.1056\/nejmicm1809669.","journal-title":"N Engl J Med"},{"key":"1126_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3935","volume":"11","author":"P Gupta","year":"2019","unstructured":"Gupta P, Shruti S, Chaudhary V, Khullar G, Siraj F. Juvenile dermatomyositis: A case report and review of literature. Cureus. 2019;11: e3935. https:\/\/doi.org\/10.7759\/cureus.3935.","journal-title":"Cureus"},{"key":"1126_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.24953\/turkjped.2019.05.018","volume":"61","author":"M \u00c7akan","year":"2019","unstructured":"\u00c7akan M, Karada\u011f \u015eG, Ayaz NA. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil. Turk J Pediatr. 2019;61:771\u20135. https:\/\/doi.org\/10.24953\/turkjped.2019.05.018.","journal-title":"Turk J Pediatr"},{"key":"1126_CR34","doi-asserted-by":"publisher","unstructured":"\u2022 Orandi AB, Dharnidharka VR, Al-Hammadi N, et al. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J. 2018;16:84. https:\/\/doi.org\/10.1186\/s12969-018-0299-9. This study helps understand the disease&apos;s response to immunobiologicals.","DOI":"10.1186\/s12969-018-0299-9"},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00296-017-3770-x","volume":"37","author":"SM Al-Mayouf","year":"2017","unstructured":"Al-Mayouf SM, Al Mutiari N, Muzaffer M, et al. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children. Rheumatol Int. 2017;37:1513\u20137. https:\/\/doi.org\/10.1007\/s00296-017-3770-x.","journal-title":"Rheumatol Int"},{"key":"1126_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10067-016-3530-4","volume":"36","author":"K Barut","year":"2017","unstructured":"Barut K, Ydin POA, Adrovic A, Sahin S, Kasapcopur O. Juvenile dermatomyositis: a tertiary center experience. Clin Rheumatol. 2017;36:361\u20136. https:\/\/doi.org\/10.1007\/s10067-016-3530-4.","journal-title":"Clin Rheumatol"},{"key":"1126_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ccr3.816","volume":"5","author":"ML Grijsen","year":"2017","unstructured":"Grijsen ML, Mchaile D, Geult I, et al. Juvenile dermatomyositis in a 4-year-old Kenyan girl. Clin Case Rep. 2017;5:134\u20138. https:\/\/doi.org\/10.1002\/ccr3.816.","journal-title":"Clin Case Rep"},{"issue":"38\u201344","key":"1126_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.01.046","volume":"184","author":"K Phillippi","year":"2017","unstructured":"Phillippi K, Hoeltzel M, Byun Robinson A, et al. Race, income, and disease outcomes in juvenile dermatomyositis. J Pediatr. 2017;184(38\u201344): e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.01.046.","journal-title":"J Pediatr"},{"key":"1126_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12969-016-0123-3","volume":"14","author":"M Ibarra","year":"2016","unstructured":"Ibarra M, Rigsby C, Morgan GA, Sammet CL, et al. Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography. Pediatr Rheumatol Online J. 2016;14:64. https:\/\/doi.org\/10.1186\/s12969-016-0123-3.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1126_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12969-016-0118-0","volume":"14","author":"LO Okong\u2019o","year":"2016","unstructured":"Okong\u2019o LO, Esser M, Wilmshurst J, Scott C. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Pediatr Rheumatol Online J. 2016;14:60. https:\/\/doi.org\/10.1186\/s12969-016-0118-0.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1126_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00296-016-3467-6","volume":"36","author":"I Saini","year":"2016","unstructured":"Saini I, Kalaivani M, Kabra SK. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol Int. 2016;36:961\u20135. https:\/\/doi.org\/10.1007\/s00296-016-3467-6.","journal-title":"Rheumatol Int"},{"key":"1126_CR42","first-page":"87","volume":"29","author":"RP Nagar","year":"2016","unstructured":"Nagar RP, Bharati J, Sheriff A, Priyadarshini P, Chumber S, Kabra SK. Calcinosis in juvenile dermatomyositis mimicking cold abscess. Natl Med J India. 2016;29:87\u20138.","journal-title":"Natl Med J India"},{"key":"1126_CR43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3109\/14397595.2014.988197","volume":"25","author":"AC Tayfur","year":"2015","unstructured":"Tayfur AC, Topaloglu R, Gulhan B, Bilginer Y. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis. Mod Rheumatol. 2015;25:615\u201320. https:\/\/doi.org\/10.3109\/14397595.2014.988197.","journal-title":"Mod Rheumatol"},{"key":"1126_CR44","doi-asserted-by":"publisher","first-page":"13030\/qt1cg4c5p","DOI":"10.5070\/D32110028957","volume":"21","author":"E Turan","year":"2015","unstructured":"Turan E, Yesilova Y, Surucu HA, et al. Juvenile dermatomyositis with joint contractures and calcinosis cutis. Dermatol Online J. 2015;21:13030\/qt1cg4c5pn.","journal-title":"Dermatol Online J"},{"key":"1126_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1546-0096-12-2","volume":"12","author":"G Faller","year":"2014","unstructured":"Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystrophic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2. https:\/\/doi.org\/10.1186\/1546-0096-12-2.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1126_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00247-013-2738-6","volume":"44","author":"J Martillotti","year":"2014","unstructured":"Martillotti J, Moote D, Zemel L. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. Pediatr Radiol. 2014;44:115\u20138. https:\/\/doi.org\/10.1007\/s00247-013-2738-6.","journal-title":"Pediatr Radiol"},{"key":"1126_CR47","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s13312-014-0531-8","volume":"251","author":"BK Meher","year":"2014","unstructured":"Meher BK, Mishra P, Sivaraj P, Padhan P. Severe calcinosis cutis with cutaneous ulceration in juvenile dermatomyositis. Indian Pediatr. 2014;251:925\u20137. https:\/\/doi.org\/10.1007\/s13312-014-0531-8.","journal-title":"Indian Pediatr"},{"key":"1126_CR48","first-page":"408","volume":"32","author":"I Pagnini","year":"2014","unstructured":"Pagnini I, Simonini G, Giani T, et al. Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. Clin Exp Rheumatol. 2014;32:408\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1126_CR49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/rhu.0000000000000199","volume":"20","author":"P Palaniappan","year":"2014","unstructured":"Palaniappan P, Lionel A, Kumar S. Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate. J Clin Rheumatol. 2014;20:454\u20135. https:\/\/doi.org\/10.1097\/rhu.0000000000000199.","journal-title":"J Clin Rheumatol"},{"key":"1126_CR50","doi-asserted-by":"publisher","first-page":"RD08","DOI":"10.7860\/JCDR\/2014\/10787.5321","volume":"8","author":"S Sanyal","year":"2014","unstructured":"Sanyal S, Atwal SS, Mondal D, Garga UC. Radiographic patterns of soft tissue calcinosis in juvenile dermatomyositis and its clinical implications. J Clin Diagn Res. 2014;8:RD08-11. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10787.5321.","journal-title":"J Clin Diagn Res."},{"key":"1126_CR51","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","volume":"53","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Shaddick G, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford). 2014;53:2204\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keu259.","journal-title":"Rheumatology (Oxford)"},{"key":"1126_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/1756-185X.12107","volume":"16","author":"PJ Gowdie","year":"2013","unstructured":"Gowdie PJ, Allen RC, Kornberg AJ, Akikusa JD. Clinical features and disease course of patients with juvenile dermatomyositis. Int J Rheum Dis. 2013;16:561\u20137. https:\/\/doi.org\/10.1111\/1756-185X.12107.","journal-title":"Int J Rheum Dis"},{"key":"1126_CR53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/1756-185X.12053","volume":"16","author":"S Prasad","year":"2013","unstructured":"Prasad S, Misra R, Agarwal V, Lawrece A, Aggarwal A. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade? Int J Rheum Dis. 2013;16:556\u201360. https:\/\/doi.org\/10.1111\/1756-185X.12053.","journal-title":"Int J Rheum Dis"},{"key":"1126_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jbspin.2012.07.001","volume":"80","author":"M Toumiy","year":"2013","unstructured":"Toumiy M, Janani S, Rachidi W, Etaouil N, Mkinsi O. Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy. Joint Bone Spine. 2013;80:108\u20139. https:\/\/doi.org\/10.1016\/j.jbspin.2012.07.001.","journal-title":"Joint Bone Spine"},{"key":"1126_CR55","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/0378-6323.102395","volume":"78","author":"L Ya-ling","year":"2021","unstructured":"Ya-ling L, Jing H, Qian L. A severe case of universal calcinosis with juvenile dermatomyositis. Indian J Dermatol Venereol Leprol. 2021;78:774. https:\/\/doi.org\/10.4103\/0378-6323.102395.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1126_CR56","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","volume":"160","author":"B Arabshahi","year":"2012","unstructured":"Arabshahi B, Silverman RA, Jones OY, Rider LG. Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J Pediatr. 2012;160:520\u20132. https:\/\/doi.org\/10.1016\/j.jpeds.2011.11.057.","journal-title":"J Pediatr"},{"key":"1126_CR57","first-page":"180","volume":"36","author":"E Cairoli","year":"2011","unstructured":"Cairoli E, Garra V, Bruzzone MJ, Gambini JP. Extensive calcinosis in juvenile dermatomyositis. Acta Reumatol Port. 2011;36:180\u20131.","journal-title":"Acta Reumatol Port"},{"key":"1126_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pediatrneurol.2011.01.018","volume":"45","author":"PJ Lorenzoni","year":"2011","unstructured":"Lorenzoni PJ, Scola RH, Kay CSK, et al. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases. Pediatr Neurol. 2011;45:17\u201322. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2011.01.018.","journal-title":"Pediatr Neurol"},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/j.1756-185X.2010.01483.x","volume":"13","author":"SM Al-Mayouf","year":"2010","unstructured":"Al-Mayouf SM, Alsonbul A, Alismail K. Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection. Int J Rheum Dis. 2010;13:e26\u20138. https:\/\/doi.org\/10.1111\/j.1756-185X.2010.01483.x.","journal-title":"Int J Rheum Dis"},{"key":"1126_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1546-0096-8-6","volume":"8","author":"T Miyamae","year":"2010","unstructured":"Miyamae T, Sano F, Ozawa R, et al. Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis. Pediatr Rheumatol Online J. 2010;8:6. https:\/\/doi.org\/10.1186\/1546-0096-8-6.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1126_CR61","first-page":"135","volume":"28","author":"AM Puche","year":"2010","unstructured":"Puche AM, Penades IC, Montesinos BL. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin Exp Rheumatol. 2010;28:135\u201340.","journal-title":"Clin Exp Rheumatol"},{"key":"1126_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken). 2010;62:63\u201372. https:\/\/doi.org\/10.1002\/acr.20015.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","volume":"60","author":"LG Rider","year":"2009","unstructured":"Rider LG, Lachenbruch PA, Monroe JB, et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum. 2009;60:3425\u201335. https:\/\/doi.org\/10.1002\/art.24904.","journal-title":"Arthritis Rheum"},{"key":"1126_CR64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","volume":"77","author":"S Slimani","year":"2010","unstructured":"Slimani S, Abdessemed A, Haddouche A, Ladjouze-Rezig A. Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. Joint Bone Spine. 2010;77:70\u20132. https:\/\/doi.org\/10.1016\/j.jbspin.2009.04.011.","journal-title":"Joint Bone Spine"},{"key":"1126_CR65","first-page":"1031","volume":"27","author":"JO Sato","year":"2009","unstructured":"Sato JO, Sallum AME, Ferriani VPL, et al. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin Exp Rheumatol. 2009;27:1031\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"1126_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1699-258X(08)75546-3","volume":"4","author":"ZM Ayala","year":"2008","unstructured":"Ayala ZM, Ram\u00edrez RM, Zer\u00f3n SM, Fuentes EF, Vel\u00e1zquez RM. Dermatomiositis juvenil y calcinosis extensa. Tratamiento con metilprednisolona y metotrexato. Reumatol Clin. 2008;4:248\u201350. https:\/\/doi.org\/10.1016\/S1699-258X(08)75546-3.","journal-title":"Reumatol Clin"},{"key":"1126_CR67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","volume":"47","author":"P Riley","year":"2008","unstructured":"Riley P, McCann LJ, Maillard SM, et al. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford). 2008;47:877\u201380. https:\/\/doi.org\/10.1093\/rheumatology\/ken074.","journal-title":"Rheumatology (Oxford)"},{"key":"1126_CR68","first-page":"784","volume":"45","author":"KR Jat","year":"2008","unstructured":"Jat KR, Singh S. Calcinosis in juvenile dermatomyositis. Indian Pediatr. 2008;45:784.","journal-title":"Indian Pediatr"},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2223\/JPED.1746","volume":"84","author":"AME Salum","year":"2008","unstructured":"Salum AME, Pivato FCMM, Doria-Filho U, et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr. 2008;84:68\u201374. https:\/\/doi.org\/10.2223\/JPED.1746.","journal-title":"J Pediatr"},{"key":"1126_CR70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1524-4725.2007.34106.x","volume":"34","author":"JJ Wu","year":"2008","unstructured":"Wu JJ, Metz BJ. Calcinosis cutis of juvenile dermatomyositis treated with incision and drainage. Dermatol Surg. 2008;34:575\u20137. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.34106.x.","journal-title":"Dermatol Surg"},{"key":"1126_CR71","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/08916930600622819","volume":"39","author":"T Constatin","year":"2006","unstructured":"Constatin T, Ponyi A, Orb\u00e1n I, et al. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary-clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity. 2006;39:223\u201332. https:\/\/doi.org\/10.1080\/08916930600622819.","journal-title":"Autoimmunity"},{"key":"1126_CR72","first-page":"68","volume":"40","author":"SK Chiu","year":"2007","unstructured":"Chiu SK, Yang YH, Wang LC, Chiang BL. Ten-year experience of juvenile dermatomyositis: a retrospective study. J Microbiol Immunol Infect. 2007;40:68\u201373.","journal-title":"J Microbiol Immunol Infect"},{"key":"1126_CR73","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1002\/art.22158","volume":"54","author":"LM Pachman","year":"2006","unstructured":"Pachman LM, Veis A, Stock S, et al. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum. 2006;54:3345\u201350. https:\/\/doi.org\/10.1002\/art.22158.","journal-title":"Arthritis Rheum"},{"key":"1126_CR74","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00296-005-0030-2","volume":"26","author":"S Singh","year":"2006","unstructured":"Singh S, Bansal A. Twelve years experience of juvenile dermatomyositis in North India. Rheumatol Int. 2006;26:510\u20135. https:\/\/doi.org\/10.1007\/s00296-005-0030-2.","journal-title":"Rheumatol Int"},{"key":"1126_CR75","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1157\/13071846","volume":"62","author":"ME Briso-Montiano","year":"2005","unstructured":"Briso-Montiano ME, S\u00e1nchez PS, Velasco MB, et al. Juvenile amyopathic dermatomyositis and calcinosis. An Pediatr (Barc). 2005;62:286\u20138. https:\/\/doi.org\/10.1157\/13071846.","journal-title":"An Pediatr (Barc)"},{"key":"1126_CR76","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1590\/S0004-282X2002000600001","volume":"60","author":"AM Sallum","year":"2022","unstructured":"Sallum AM, Kiss MHB, Sachetti S, et al. Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr. 2022;60:889\u201399. https:\/\/doi.org\/10.1590\/S0004-282X2002000600001.","journal-title":"Arq Neuropsiquiatr"},{"key":"1126_CR77","first-page":"1129","volume":"28","author":"L Harel","year":"2001","unstructured":"Harel L, Harel G, Korenreich L, Straussberg R, Amir J. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol. 2001;28:1129\u201332.","journal-title":"J Rheumatol"},{"key":"1126_CR78","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1067\/mpd.2001.112473","volume":"138","author":"M Mukamel","year":"2001","unstructured":"Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr. 2001;138:763\u20136. https:\/\/doi.org\/10.1067\/mpd.2001.112473.","journal-title":"J Pediatr"},{"key":"1126_CR79","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"AM Huber","year":"2000","unstructured":"\u2022\u2022 Huber AM, Lang B, LeBlanc CM, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum. 2000;43:541\u20139. https:\/\/doi.org\/10.1002\/1529-0131(200003)43:3%3c541::AID-ANR9%3e3.0.CO;2-T. This study describes a cohort that helps understand the natural history of the disease.","journal-title":"Arthritis Rheum"},{"key":"1126_CR80","first-page":"1198","volume":"25","author":"LM Pachman","year":"1998","unstructured":"Pachman LM, Hayford JR, Chung A, et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol. 1998;25:1198\u2013204.","journal-title":"J Rheumatol"},{"key":"1126_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1442-200x.1997.tb03595.x","volume":"39","author":"S Kobayashi","year":"1997","unstructured":"Kobayashi S, Higuchi K, Tamaki H, et al. Characteristics of juvenile dermatomyositis in Japan. Pediatr Int. 1997;39:257\u201362. https:\/\/doi.org\/10.1111\/j.1442-200x.1997.tb03595.x.","journal-title":"Pediatr Int"},{"key":"1126_CR82","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-0960.1997.tb01698.x","volume":"38","author":"S Wanakul","year":"1997","unstructured":"Wanakul S, Pongprasit P, Wattakankrai P. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases. Australas J Dermatol. 1997;38:202\u20135. https:\/\/doi.org\/10.1111\/j.1440-0960.1997.tb01698.x.","journal-title":"Australas J Dermatol"},{"key":"1126_CR83","first-page":"2152","volume":"23","author":"MB Oliveri","year":"1996","unstructured":"Oliveri MB, Palermo R, Mautalen C, H\u00fcbscher O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol. 1996;23:2152\u20135.","journal-title":"J Rheumatol"},{"key":"1126_CR84","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1346-8138.1993.tb01338.x","volume":"20","author":"T Nakagawa","year":"1993","unstructured":"Nakagawa T, Taikawa T. Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment. J Dermatol. 1993;20:558\u201390. https:\/\/doi.org\/10.1111\/j.1346-8138.1993.tb01338.x.","journal-title":"J Dermatol"},{"key":"1126_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15960","volume":"35","author":"M Agud-Dios","year":"2022","unstructured":"Agud-Dios M, Arroyo-Andres J, Rubio-Mu\u00f1iz C, et al. Juvenile dermatomyositis-associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy. Dermatol Ther. 2022;35: e15960. https:\/\/doi.org\/10.1111\/dth.15960.","journal-title":"Dermatol Ther"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-023-01126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-023-01126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-023-01126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T04:21:07Z","timestamp":1705119667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-023-01126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s11926-023-01126-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"21 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}